National Academies Press: OpenBook

The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies (2013)

Chapter: Appendix G: Institute of Medicine Publications on Vaccines

« Previous: Appendix F: Biographical Sketches of Committee Members
Suggested Citation:"Appendix G: Institute of Medicine Publications on Vaccines." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×

Appendix G

Institute of Medicine Publications on Vaccines

  • Adverse Effects of Vaccines: Evidence and Causality (2012)
  • Ranking Vaccines: A Prioritization Framework: Phase I: Demonstration of Concept and a Software Blueprint (2012)
  • “A Perspective on Vaccines,” President’s Address, Institute of Medicine Annual Meeting, Washington, DC (2011)
  • The 2009 H1N1 Influenza Vaccination Campaign: Summary of a Workshop Series (2010)
  • The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary (2009)
  • Live Variola Virus: Considerations for Continuing Research (2009)
  • Priorities for the National Vaccine Plan (2009)
  • Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office (2008)
  • Battling Malaria: Strengthening the U.S. Military Malaria Vaccine Program (2006)
  • John R. La Montagne Memorial Symposium on Pandemic Influenza Research: Meeting Proceedings (2006)
  • The Smallpox Vaccination Program: Public Health in an Age of Terrorism (2005)
  • Vaccine Safety Research, Data Access, and Public Trust (2005)
  • Immunization Safety Review: Influenza Vaccines and Neurological Complications (2004)
  • Immunization Safety Review: Vaccines and Autism (2004)
Suggested Citation:"Appendix G: Institute of Medicine Publications on Vaccines." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
  • Financing Vaccines in the 21st Century: Assuring Access and Availability (2003)
  • Immunization Safety Review: Vaccinations and Sudden Unexpected Death in Infancy (2003)
  • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 1 (2003)
  • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 2 (2003)
  • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 3 (2003)
  • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 4 (2003)
  • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 5 (2003)
  • Review of the Centers for Disease Control and Prevention’s Smallpox Vaccination Program Implementation, Letter Report 6 (2003)
  • Setting the Course—A Strategic Vision for Immunization. Part 3: Summary of the Los Angeles Workshop (2003)
  • Setting the Course—A Strategic Vision for Immunization. Part 4: Summary of the Washington, DC, Workshop (2003)
  • The Anthrax Vaccine: Is It Safe? Does It Work? (2002)
  • An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program (2002)
  • Considerations for Viral Disease Eradication: Lessons Learned and Future Strategies (2002)
  • Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (2002)
  • Immunization Safety Review: Multiple Immunizations and Immune Dysfunction (2002)
  • Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer (2002)
  • Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military (2002)
  • Scientific and Policy Considerations in Developing Smallpox Vaccination Options: A Workshop Report (2002)
  • Setting the Course—A Strategic Vision for Immunization Finance. Part 1: Summary of the Chicago Workshop (2002)
  • Setting the Course—A Strategic Vision for Immunization. Part 2: Summary of the Austin Workshop (2002)
  • Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism (2001)
  • Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders (2001)
Suggested Citation:"Appendix G: Institute of Medicine Publications on Vaccines." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
  • Statement from the IOM Council on Vaccine Development (2001)
  • An Assessment of the Safety of the Anthrax Vaccine: A Letter Report (2000)
  • Calling the Shots: Immunization Finance Policies and Practices (2000)
  • Urgent Attention Needed to Restore Lapsed Adenovirus Vaccine Availability: A Letter Report (2000)
  • Vaccines for the 21st Century: A Tool for Decisionmaking (2000)
  • Assessment of Future Scientific Needs for Live Variola Virus (1999)
  • Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices (1999)
  • Detecting and Responding to Adverse Events Following Vaccination: Workshop Summary (1997)
  • Research to Identify Risks for Adverse Events Following Vaccination: Biological Mechanisms and Possible Means of Prevention: Workshop Summary (1997)
  • Risk Communication and Vaccination: Workshop Summary (1997)
  • Options for Poliomyelitis Vaccination in the United States: Workshop Summary (1996)
  • Vaccines Against Malaria: Hope in a Gathering Storm (1996)
  • The Children’s Vaccine Initiative: Continuing Activities (1995)
  • Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality (1994)
  • DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis (1994)
  • Research Strategies for Assessing Adverse Events Associated with Vaccines: A Workshop Summary (1994)
  • The Children’s Vaccine Initiative: Achieving the Vision (1993)
  • Adverse Effects of Pertussis and Rubella Vaccines (1991)
  • The Potential Value of Research Consortia in the Development of Drugs and Vaccines Against HIV Infection and AIDS (report of a workshop) (1989)
  • An Evaluation of Poliomyelitis Vaccine: Policy Options (1988)
  • Prospects for Vaccines Against HIV Infection (1988)
  • Temperature-Stable Vaccines for Developing Countries: Significance and Development Strategies (1987)
  • New Vaccine Development: Establishing Priorities. Volume II, Diseases of Importance in Developing Countries (1986)
  • New Vaccine Development: Establishing Priorities. Volume I, Diseases of Importance in the United States (1985)
  • Vaccine Supply and Innovation (1985)
  • Evaluation of Poliomyelitis Vaccines (1977)
Suggested Citation:"Appendix G: Institute of Medicine Publications on Vaccines." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×

This page is blank

Suggested Citation:"Appendix G: Institute of Medicine Publications on Vaccines." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 217
Suggested Citation:"Appendix G: Institute of Medicine Publications on Vaccines." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 218
Suggested Citation:"Appendix G: Institute of Medicine Publications on Vaccines." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 219
Suggested Citation:"Appendix G: Institute of Medicine Publications on Vaccines." Institute of Medicine. 2013. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies. Washington, DC: The National Academies Press. doi: 10.17226/13563.
×
Page 220
The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies Get This Book
×
Buy Paperback | $47.00 Buy Ebook | $37.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Vaccines are among the most safe and effective public health interventions to prevent serious disease and death. Because of the success of vaccines, most Americans today have no firsthand experience with such devastating illnesses as polio or diphtheria. Health care providers who vaccinate young children follow a schedule prepared by the U.S. Advisory Committee on Immunization Practices. Under the current schedule, children younger than six may receive as many as 24 immunizations by their second birthday. New vaccines undergo rigorous testing prior to receiving FDA approval; however, like all medicines and medical interventions, vaccines carry some risk.

Driven largely by concerns about potential side effects, there has been a shift in some parents' attitudes toward the child immunization schedule. The Childhood Immunization Schedule and Safety identifies research approaches, methodologies, and study designs that could address questions about the safety of the current schedule.

This report is the most comprehensive examination of the immunization schedule to date. The IOM authoring committee uncovered no evidence of major safety concerns associated with adherence to the childhood immunization schedule. Should signals arise that there may be need for investigation, however, the report offers a framework for conducting safety research using existing or new data collection systems.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!